Harmony Biosciences Holdings, Inc.
Status: Publicly traded
Direct answer
Harmony Biosciences Holdings, Inc. is publicly traded on NASDAQ under the ticker HRMY.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known...
Can you invest in Harmony Biosciences Holdings, Inc.?
Yes. Harmony Biosciences Holdings, Inc. trades publicly on NASDAQ as HRMY.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Harmony Biosciences Holdings, Inc.
Detailed equity research is provided by MarketSnap.